# A Non-Traumatic Binder for Temporary Abdominal Wall Closure

Study · id `cardio:ct-nct03815370` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03815370](<https://clinicaltrials.gov/study/NCT03815370>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT03815370

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 140 participants.

## Technical summary

Registry record NCT03815370. Randomized; no masking; primary purpose treatment. Start 2019-04-01 (actual); primary completion 2022-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 140 participants (planned count; ClinicalTrials.gov record NCT03815370, source copy `cardio:ctgov-nct03815370-2022-03-10`, retrieved 2026-11-18)
- Started: 2019-04-01 (actual) (ClinicalTrials.gov record NCT03815370, source copy `cardio:ctgov-nct03815370-2022-03-10`, retrieved 2026-11-18)
- Primary completion: 2022-12-31 (anticipated) (ClinicalTrials.gov record NCT03815370, source copy `cardio:ctgov-nct03815370-2022-03-10`, retrieved 2026-11-18)
- Completion: 2023-03-30 (anticipated) (ClinicalTrials.gov record NCT03815370, source copy `cardio:ctgov-nct03815370-2022-03-10`, retrieved 2026-11-18)
- Countries: Canada (ClinicalTrials.gov record NCT03815370, source copy `cardio:ctgov-nct03815370-2022-03-10`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03815370-2022-03-10`, retrieved 2026-11-18)

## The registry's words

- Brief title: A Non-Traumatic Binder for Temporary Abdominal Wall Closure
- Acronym: ABRO
- Condition: Abdominal Trauma
- Condition: Abdominal Injury
- Condition: Abdominal Infection
- Condition: Abdominal Sepsis
- Condition: Abdominal Abscess
- Condition: Abdominal Aneurysm
- Condition: Abdominal Compartment Syndrome
- Condition: Peritonitis
- Intervention (Device): Experimental: ABRO™ Binder Arm
- Intervention (Device): Placebo Comparator: Usual Care
- Lead sponsor: Unity Health Toronto
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Abdominal aortic aneurysm (`cardio:abdominal-aortic-aneurysm`)
- Registry lists this organization as the lead sponsor: Unity Health Toronto (`cardio:org-unity-health-toronto`)

## Provenance

Content hash: 23b7a6e283bb698b273afeb6823c5dcebba07cd0575a404540ef163a54a17d10
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
